The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis
Abstract
BACKGROUND AND AIMS Biannual ultrasound (US) has poor sensitivity in screening of hepatocellular carcinoma (HCC). Magnetic resonance imaging (MRI) is accurate for detection of HCC, but a complete MRI (cMRI) is not feasible as a screening tool. Abbreviated MRI (AMRI) is an acceptable alternative. The diagnostic performance of different AMRI protocols in not known. We performed a systematic review to determine the diagnostic accuracy of AMRI in HCC screening. METHODS We searched the MEDLINE and EMBASE databases for studies reporting the diagnostic accuracy of AMRI in screening of HCC. The pooled sensitivity and specificity of different AMRI protocols were calculated based on random intercept logistic regression model. The diagnostic performance of AMRI was compared with US. Quality of studies was assessed using QUADAS-2 tool. RESULTS Of the 11327 studies screened by titles, 15 studies (3 prospective and 12 retrospective, 2807 patients, 917 HCC) were included in the final analysis. The pooled per-patient sensitivity and specificity were 86% (95% CI: 84%-88%, I2 0%) and 94% (95% CI: 91-96%, I2 83%), respectively. Pooled per-lesion sensitivity was 77% (95% CI: 74-81%, I2 8%). There was no influence of study type, screening setting, reference standard, and presence and etiology of cirrhosis on the performance of AMRI. The sensitivity of AMRI for detection of HCC<2 cm was lower than that for HCC≥2cm (69% vs. 86%). The sensitivity and specificity of NC-AMRI were comparable to CE-AMRI [86% and 94% vs.87% and 94%]. The diagnostic performance of different NC-AMRI and CE-AMRI protocols was comparable. The sensitivity of US was lower than AMRI (53% vs. 82%). CONCLUSIONS AMRI has high sensitivity and specificity for HCC screening. Different AMRI protocols have comparable diagnostic performance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Kim, S. Y., An, J., Lim, Y.-S., Han, S., Lee, J.-Y., Byun, J. H., Won, H. J., Lee, S. J., Lee, H. C., & Lee, Y. S. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.3147 · Cited by 356
Cited by
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
Singal, A. G., Llovet, J. M., Yarchoan, M., Mehta, N., Heimbach, J. K., Dawson, L. A., Jou, J. H., Kulik, L. M., Agopian, V. G., Marrero, J. A., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000466 · Cited by 2,052
“[84,85] Early data suggest MRI-based surveillance may have poorer performance in patients with Child-FIGURE Overall value of hepatocellular carcinoma (HCC) surveillance is determined by balance of benefits and harms.”
Singal, A. G., Kanwal, F., & Llovet, J. M. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00825-3 · Cited by 951
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0294 · Cited by 343
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Hwang, S. Y., Danpanichkul, P., Agopian, V., Mehta, N., Parikh, N. D., Abou-Alfa, G. K., Singal, A. G., & Yang, J. D. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0824 · Cited by 306
Rational HCC screening approaches for patients with NAFLD
Singal, A. G., & El-Serag, H. B. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.08.028 · Cited by 80
Metadata
- Authors
- Gupta, P., Soundararajan, R., Patel, A., Kumar-M, P., Sharma, V., & Kalra, N.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 75
- Issue
- 1
- Pages
- 108-119
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W3126354613
- Cited by
- 178
- References
- 3
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis. https://app.cochat.ai/papers/10.1016/j.jhep.2021.01.041
- The paper
- Gupta, P., Soundararajan, R., Patel, A., Kumar-M, P., Sharma, V., & Kalra, N. (2021). Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2021.01.041
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.